2005P-0411
  

  
 Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs

  


  

  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC350
  



  

  
Submitter : 
  

  
Ms. Melanie Parker
  

  
Date & Time: 
  

  
01/26/2006 02:01:35
  



  

  
Organization : 
  

  
Ms. Melanie Parker
  



  

  
Category : 
  

  
Health Professional
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 It is imperative that the American health consumer retain the right to choose an alternative to conventional pharmaceutical products for hormone replacement therapy. Bioidentical hormones have been shown to metabolize into a significantly safer profile of byproducts than pharm-engineered hormones do. To take away the American health consumer's right to choose hormone replacement identical to the hormones found in their own bodies would be a flagrant abuse of federal executive power.